Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest - a Randomized Clinical Trial

NCT03863015 is registered in ClinicalTrials.gov with Christian Hassager as lead sponsor.

NCT NCT03863015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03863015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest - a Randomized Clinical Trial
Lead sponsor
Christian Hassager
Phase
Phase 2
Overall status
Completed
Start date
March 4, 2019
Completion date
June 30, 2020
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart arrest, out-of-hospital cardiac arrest, systemic inflammatory response syndrome